Agitation drug put to the test: does stopping cause problems?
NCT ID NCT06041646
Summary
This study looked at what happens when people with schizophrenia or bipolar disorder stop taking a short-term medication for agitation. Researchers gave 29 adults the drug Igalmi as needed for 7 days to calm agitation episodes, then monitored them for 3 days after stopping. The main goal was to check if stopping the medication caused withdrawal symptoms or if the drug became less effective with repeated use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioXcel Clinical Research Site
Little Rock, Arkansas, 72211, United States
-
BioXcel Clinical Research Site
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.